Karaman, Çelik, Kiran, Colak, and Daldal: Malondialdehyde, Glutathione, and Nitric Oxide Levels in Toxoplasma gondii Seropositive Patients
Cited By
Citations to this article as recorded by
Modulation of immunity in mice with latent toxoplasmosis—the experimental support for the immunosuppression hypothesis of Toxoplasma-induced changes in reproduction of mice and humans
Šárka Kaňková, Vladimír Holáň, Alena Zajícová, Petr Kodym, Jaroslav Flegr
Parasitology Research.2010; 107(6): 1421.     CrossRef
Oxidative stress and tryptophan degradation pattern of acute Toxoplasma gondii infection in mice
Ayse Basak Engin, Funda Dogruman-Al, Ugur Ercin, Bekir Celebi, Cahit Babur, Neslihan Bukan
Parasitology Research.2012; 111(4): 1725.     CrossRef
Effect of Nigella sativa oil on experimental toxoplasmosis
Rasha F. Mady, Wessam El-Hadidy, Samar Elachy
Parasitology Research.2016; 115(1): 379.     CrossRef
Potential effects of alpha-pinene, a monoterpene commonly found in essential oils against Toxoplasma gondii infection; an in vitro and in vivo study
Ali Kharazmkia, Hiba Riyadh Al-Abodi, Javad Ghasemian Yadegari, Ashkan Vahidi, Hossein Mahmoudvand
Journal of Parasitic Diseases.2022; 46(4): 1055.     CrossRef
Treatments of Mycobacterium tuberculosis and Toxoplasma gondii with Selenium Nanoparticles
Ikhazuagbe H. Ifijen, Best Atoe, Raphael O. Ekun, Augustine Ighodaro, Ifeanyi J. Odiachi
BioNanoScience.2023; 13(1): 249.     CrossRef
Tuberculosis/toxoplasmosis co-infection in Egyptian patients: A reciprocal impact
Mervat Mashaly, Nairmen Nabih, Iman M. Fawzy, Abeer A. El Henawy
Asian Pacific Journal of Tropical Medicine.2017; 10(3): 315.     CrossRef
Stromal–epithelial metabolic coupling in cancer: Integrating autophagy and metabolism in the tumor microenvironment
Ubaldo E. Martinez-Outschoorn, Stephanos Pavlides, Anthony Howell, Richard G. Pestell, Herbert B. Tanowitz, Federica Sotgia, Michael P. Lisanti
The International Journal of Biochemistry & Cell Biology.2011; 43(7): 1045.     CrossRef
Amelioration of glucose induced hemolysis of human erythrocytes by vitamin E
Thankamani Marar
Chemico-Biological Interactions.2011; 193(2): 149.     CrossRef
Discovery and evaluation of chalcone derivatives as novel potential anti-Toxoplasma gondii agents
Liping Jiang, Bo Liu, Shengjie Hou, Tiande Su, Qiyun Fan, Eman Alyafeai, Yaqin Tang, Mengqi Wu, Xiaohua Liu, Jing Li, Yu Hu, Wulan Li, Zhiwei Zheng, Yuan Liu, Jianzhang Wu
European Journal of Medicinal Chemistry.2022; 234: 114244.     CrossRef
Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo
Xiaochuan Zhang, Lili Jin, Zhe Cui, Changhao Zhang, Xue Wu, Hyun Park, Hongmei Quan, Chunmei Jin
Experimental Parasitology.2016; 165: 95.     CrossRef
More than an association: Latent toxoplasmosis might provoke a local oxidative stress that triggers the development of bipolar disorder
Mohammed A. Afifi, Asif A. Jiman-Fatani, Mohammed W. Al-Rabia, Nabeel H. Al-Hussainy, Sherif El Saadany, Wael Mayah
Journal of Microscopy and Ultrastructure.2017;[Epub]     CrossRef
Delta-aminolevulinate dehydratase enzyme activity and the oxidative profile of pregnant women being treated for acute toxoplasmosis
Hellen Lopes de Paula, Leidiane de Lucca, Silmara Ana Vendrame, Ligia Carine Wess, Carolina dos Santos Stein, Rafael Noal Moresco, Sandra Trevisan Beck, Thissiane de Lima Gonçalves
Microbial Pathogenesis.2022; 164: 105455.     CrossRef
Comparative study of oxidative stress and antioxidative markers in patients infected with Toxoplasma gondii
Marisa Lúcia Romani Paraboni, Vanusa Manfredini, Gênifer Erminda Schreiner, Itamar Luís Gonçalves, Claudio Silveira, Alessandra Gonçalves Commodaro, Rubens Belfort Jr
Parasitology International.2022; 91: 102645.     CrossRef
Metabolic, immune, epigenetic, endocrine and phenotypic abnormalities found in individuals with autism spectrum disorders, Down syndrome and Alzheimer disease may be caused by congenital and/or acquired chronic cerebral toxoplasmosis
Joseph Prandota
Research in Autism Spectrum Disorders.2011; 5(1): 14.     CrossRef
Low molecular weight thiols reduce thimerosal neurotoxicity in vitro: Modulation by proteins
E. Zieminska, B. Toczylowska, A. Stafiej, J.W. Lazarewicz
Toxicology.2010; 276(3): 154.     CrossRef
Lipo-polymeric nano-complexes for dermal delivery of a model protein
Abhay Tharmatt, Deepak Kumar Sahel, Reena Jatyan, Anupma Kumari, Amit Mishra, Anupama Mittal, Deepak Chitkara
RSC Advances.2024; 14(28): 20351.     CrossRef
Extracts of Tectona grandis and Vernonia amygdalina have anti-Toxoplasma and pro-inflammatory properties in vitro
Mlatovi Dégbé, Françoise Debierre-Grockiego, Amivi Tété-Bénissan, Héloïse Débare, Kodjo Aklikokou, Isabelle Dimier-Poisson, Messanvi Gbeassor
Parasite.2018; 25: 11.     CrossRef
Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms
Federica Sotgia, Ubaldo E. Martinez-Outschoorn, Anthony Howell, Richard G. Pestell, Stephanos Pavlides, Michael P. Lisanti
Annual Review of Pathology: Mechanisms of Disease.2012; 7(1): 423.     CrossRef
New-Onset Cervical Lymphadenopathy in a Patient Undergoing Treatment of Pulmonary Mycobacterium avium Complex Infection: Toxoplasmosis Lymphadenitis
Chia-Yu Chiu, Amara Sarwal, Peter Yangga, Dasol Kang, Addi Feinstein
Case Reports in Infectious Diseases.2020; 2020: 1.     CrossRef
Role of oxidative stress in the pathophysiology of Toxoplasma gondii infection
Gungor Cagdas Dincel, Hasan Tarik Atmaca
International Journal of Immunopathology and Pharmacology.2016; 29(2): 226.     CrossRef
Dynamic RNA profiles in the small intestinal epithelia of cats after Toxoplasma gondii infection
Bintao Zhai, Shi-Chen Xie, Jiyu Zhang, Jun-Jun He, Xing-Quan Zhu
Infectious Diseases of Poverty.2023;[Epub]     CrossRef
Analysis of oxidative status, inflammatory cytokines, and Ascaris lumbricoides infection in women at a health district in Bamenda, Northwest, Cameroon
Bashi Brenda Mugob, Ntonifor Helen Ngum, Clifford Boubga, Foncham Evans Ngwenah, Oumar Mahamat
The Egyptian Journal of Internal Medicine.2024;[Epub]     CrossRef
Comparative Study of Oxidative Stress and Antioxidative Markers in Patients Infected with Toxoplasma Gondii
Marisa Lúcia Romani Paraboni, Vanusa Manfredini, Genifer Erminda Schreiner, Itamar Luís Gonçalves, Claudio Silveira, Alessandra Gonçalves Commodaro, Rubens Belfort Jr
SSRN Electronic Journal.2022;[Epub]     CrossRef
Evaluation of Glutathione Bioactivity on Toxoplasma Gondii in BALB/c Mice Post Impact of Selenium and Calcium Supplementation
Mohammad Javad Namazi, Saeideh Nikpour, Parvaneh Rahimi-Moghaddam, Seyed Abdollah Hosseini, Abolghasem Siyadatpanah, Neda Sadat Shokouhi Mostafavi, Rahim Golmohammadi, Fatemeh Tabatabaie
Infectious Disorders - Drug Targets .2021; 21(3): 452.     CrossRef
Determination of Malondialdehyde, Nitric Oxide, Reduced Glutathione, Sialic Acid and Ceruloplasmin Levels in Sheep Liver Tissue With Hydatic Cyst
Semistan Kızıltepe, Çağlar Okulmuş, Oğuz Merhan, Neriman Mor, Erdoğan Uzlu
Kocatepe Veterinary Journal.2024; 17(1): 55.     CrossRef
Evaluation of Oxidative Stress in Sheep with Toxoplasma gondii by Malondialdehyde, Glutathione Levels, Total Oxidant Status, Total Antioxidant Capacity and Oxidative Stress Index Markers
Nergis ULAŞ, Mustafa Sinan AKTAŞ, Kerim Emre YANAR, Ömer AYDIN, Muhammed Sertaç EROĞLU, Emre EREN
Erciyes Üniversitesi Veteriner Fakültesi Dergisi.2022; 19(3): 182.     CrossRef
In Vitro and in Vivo Effects of Nitrofurantoin on Experimental Toxoplasmosis
Seon-Ju Yeo, ChunMei Jin, SungYeon Kim, Hyun Park
The Korean Journal of Parasitology.2016; 54(2): 155.     CrossRef
Evaluation of the anti-Toxoplasma gondii Activity of Hederagenin in vitro and in vivo
Run-Hui Zhang, Runhao Jin, Hao Deng, Qing-Kun Shen, Zhe-Shan Quan, Chun-Mei Jin
The Korean Journal of Parasitology.2021; 59(3): 297.     CrossRef
Oxidative Stress as a Possible Target in the Treatment of Toxoplasmosis: Perspectives and Ambiguities
Karolina Szewczyk-Golec, Marta Pawłowska, Roland Wesołowski, Marcin Wróblewski, Celestyna Mila-Kierzenkowska
International Journal of Molecular Sciences.2021; 22(11): 5705.     CrossRef
Nano-Encapsulated Melatonin: A Promising Mucosal Adjuvant in Intranasal Immunization against Chronic Experimental T. gondii Infection
Doaa E. Said, Eglal I. Amer, Eman Sheta, Shaimaa Makled, Hala E. Diab, Fadwa M. Arafa
Tropical Medicine and Infectious Disease.2022; 7(12): 401.     CrossRef
Nano-Encapsulated Antioxidant: Retinoic Acid as a Natural Mucosal Adjuvant for Intranasal Immunization against Chronic Experimental Toxoplasmosis
Doaa E. Said, Eglal I. Amer, Eman Sheta, Shaimaa Makled, Fadwa M. Arafa, Hala E. Diab
Tropical Medicine and Infectious Disease.2023; 8(2): 106.     CrossRef
Toksoplazmozisli Koyunlarda Oksidatif Stres ve Seruloplazmin Düzeylerinin Belirlenmesi
Kadir BOZUKLUHAN, Oğuz MERHAN, Şemistan KIZILTEPE, Ahmet HARMANKAYA, Gürbüz GÖKÇE
Van Veterinary Journal.2020; 31(2): 83.     CrossRef
Toxoplasmosis and Risk of Endothelial Dysfunction: Role of Oxidative Stress and Pro-Inflammatory Mediators
Hayder M. Al-Kuraishy, Azhar H. Al-Kuraishi, Salah Al-Windy, Ali I. Al-Gareeb
Archives of Clinical Infectious Diseases.2020;[Epub]     CrossRef

Abstract

The aim of this study was to investigate the difference in the serum malondialdehyde (MDA), glutathione (GSH), and nitric oxide (NO) levels between normal and T. gondii-infected patients. To this end, MDA, GSH, and NO levels in the sera of 37 seropositive patients and 40 participants in the control group were evaluated. In Toxoplasma ELISA, IgG results of the patient group were 1,013.0 ± 543.8 in optical density (mean ± SD). A statistically significant difference was found between patients and the control group in terms of MDA, GSH, and NO levels. A decrease in GSH activity was detected, while MDA and NO levels increased significantly. Consequently, it is suggested that the use of antioxidant vitamins in addition to a parasite treatment shall prove useful. The high infection vs control ratio of MDA and NO levels probably suggests the occurrence as a mechanism of tissue damage in cases of chronic toxoplasmosis. Moreover, it is recommended that the patient levels of MDA, GSH, and NO should be evaluated in toxoplasmosis.

Toxoplasma gondii is a highly frequent obligate intracellular protozoan parasite. It is reported that about one-third of the world population is infected with T. gondii, and the disease has asymptomatic progress in 90% of the patients with sound immune systems [1,2]. Toxoplasmosis can cause serious pathologies including hepatitis, pneumonia, blindness, and severe neurological disorders. These types of diseases are seen particularly in people with weak immune systems [3,4]. Yet, the pathogenic mechanisms in healthy people could not be explained completely.
It is assumed that the malondialdehyde (MDA) arising from the lipid peroxidation is an indicator of the oxidative stress in tissue and cells. Lipid peroxidase is a derivative enzyme of feeble unsaturated fatty acid which is produced as a result of decomposition of a set of complex components [5]. Glutathione (GSH), an endogen-originated peptide which can be synthesized in the liver without need for genetic data, is made up of glutamic acid, cysteine and glycine amino acids, and is an important antioxidant. It defends the cells against oxidative damage by undergoing reaction with free radicals and peroxidase [6]. The activity of inducible nitric oxide synthase (INOS) enzyme is independent of calcium and is active as long as there is argine involved. In this case it can catalyze nitric oxide (NO) synthesis at long-termed and high concentration. Most of the basic antioxidants have been examined in protozoans and helminths [7-9]. The aim of the present study was to investigate the difference of MDA, GSH, and NO levels in sera of normal and T. gondii-infected patients (IgG seropositive but without symptoms).
Prior to the study the approval of the ethical council was obtained and only those patients voluntary to donate samples were included. The materials were examined in the Parasitology and Biochemistry Laboratory in Faculty of Medicine at Inonu University, Malatya, Turkey during 2005-2007. The sera from 37 T. gondii seropositive patients and 40 participants in the control group were checked for MDA, GSH, and NO levels. The age of the experimental group was 30.6 ± 5.5 yr on average with 3 males and 34 females. The all-man participants in the control group aged 40.3 ± 5.8 yr on average. Serum samples for the control group were obtained from healthy people who had referred to the different Departments of Inonu University/Medical Faculty for a regular check-up and from students or employees of the University.
All of the subjects fasted after midnight before blood collection in the next morning. Given the fact that increases in MDA levels can be observed in parasitic diseases, the participants in both patients and control groups were examined for their intestinal parasites using native lugol, cellophaned perianal region material, and sedimentation methods. The cyst hydatid, in addition, was evaluated using manual indirect hemagglutination (IHA) test and indirect fluorescent antibody test (IFAT). The experimental group was formed out of those patients found to be T. gondii seropositive using ELISA and IFAT tests alone. Besides, among T. gondii seropositive patients, those with parasites detected in their feces, using a hormonal medication, smoking, and drinking alcohol were excluded from the study since they are likely to give rise to differences in MDA, GSH, and NO levels. Also ELISA and IFAT tests were used in order to detect anti-T. gondii antibodies. The brands of the kits used in ELISA and IFAT tests are Meddens and Zeus, respectively. All of the samples were found IgM seronegative. Among volunteers in the control group, only those who had no parasitic infections, no smoking or drinking habits, and who did not take any hormonal medication were included in the study. Those patients found to be positive in ELISA and IFAT tests were invited once again and informed about the study results. Then, blood samples of 5 ml were taken from those willing. Next the sera were separated from the samples and kept under -20℃ until analysis.
All venous blood samples were taken between 8:00 and 9:00 a.m. after 12 hr of fasting and collected in polystyrene tubes and vacutainers containing heparin. The tubes were centrifuged at 500 × g for 15 min. The serum was then removed and stored at -20℃ until analysis. Serum MDA levels were determined using the Uchiyama-Mihara method [6]. Briefly, 1 ml of 0.6% thiobarbituric acid solution, 3 ml 1% phosphoric acid, and 0.5 ml of 10% tissue homogenate were put into a tube. This mixture was heated in boiled water for 45 min. An extract was obtained by adding 4 ml of n-butanol in cooled tubes and then MDA passing into the serum was measured using spectrophotometer at 532 nm wave-length. The serum MDA amount was measured in nmol/L. Glutathione designation was calculated in µmol/L after evaluating the yellow product at 410 nm wave-length which was observed as a result of the reaction of sulphydryl groups with the Elman reagent [10]. Colored compound produced, when the nitrite formed though NO system activity (considering the total amount of nitrite) as a result of cadmium-reduction of nitrate (NO3-) to nitrite (NO2-) was reacted with Griess reactive, was measured at 545 nm by a spectrophotometer. The results were given in µmol/L.
The data were given in means and standard errors, and the normality test was done with Shapiro-Wilk method. Also independent samples t-test was used for the statistical analysis. P < 0.05 was considered statistically significant.
Descriptive statistics on the MDA level, GSH, and NO activities were shown in Table 1. The anti-T. gondii ELISA IgG results of the patient group were 1,013.0 ± 543.8 in optical density (mean ± SD). The ELISA IgG values were found negative for the control group. Anti-T. gondii IFAT results measuring 1/16 and more in the patient group were considered positive (Table 1). Statistically significant differences were found between the patients and the control group in terms of MDA, GSH, and NO parameters (P < 0.05).
T. gondii is an obligate intracellular parasite frequently occurring in cystic forms in humans. T-cells in cellular immune systemcontrols the growth of the parasite. Moreover, macrophages, fibroblasts, astrocytes, and microglial cells in the brain are the cells capable of restricting the proliferation of toxoplasmosis. Also it is known that the major anti-parasitic effector mechanisms stimulate the production of NO by activating indolamine 2,3-dioxygenase (IDO) activity and the INOS [11,12]. TNF-α, a cytokine secreted from the activated macrophage and monocytes, is responsible for the toxoplasmocidal effects of macrophages via IFN-γ and necessary for the synthesis of NO, which can suppress the proliferation of toxoplasmosis, from macrophages. In a previous study, the serum TNF-α level in patients with acute toxoplasmosis was found higher than the level in patients with chronic toxoplasmosis and in healthy people of the control group. It was reported that this parasite has enzymes which produce free oxygen radicals such as superoxide and hydrogen peroxide [4,11]. It was suggested that it can play a role in the pathogenesis of acute toxoplasmosis. NO is the product of arginine metabolism and one of the most effective O2-free toxins. There are also previous studies reporting an increase in the NO level in parasitic diseases [1,12]. It can be stated that the NO level increases as a defensive mechanism to protect the patient against the harmful effects of the parasite.
One of the products of the lipid peroxidation is MDA. MDA arises from peroxidation of fatty acids containing 3 or more double bonds. The MDA product can cause the cross-linkage of membrane elements by affecting the ion exchange from cell membranes, which gives way to aftermaths including a change in ion permeability and enzyme activity. In a previous study, it was reported that MDA increases in Toxoplasma seropositive patients [13]. Again in this study, an increase in the MDA level was detected. It was reported that increased MDA activity in lymphocytes and erythrocytes in the dust-mite positive or skin test positive group shows the presence of the oxidative stress in patients with dust-mite infestation [14].
The potentially harmful effects of reactive oxygen species are controlled by the cellular antioxidant defense system. GSH is an important constituent of intracellular protective mechanisms against a number of noxious stimuli including oxidative stress. It plays a role in preventing the transformation of hemoglobin into methemoglobin due to oxidation. Moreover, it maintains the sulfhydryl (-SH) groups in proteins in a reduced state and protects these groups against oxidation [15]. In the present study, the significant decrease found in GSH activity in the patient group can be explained with the oxidative stress caused by lipid peroxidation and depletion in the GSH level, which is an endogen antioxidant. Thus, it is suggested that antioxidant vitamins (E and C) increase the GSH activity (one of the cell-protective factors) [16].
As far as we know, there is no previous research which studied MDA and NO levels, and GSH activities together in Toxoplasma seropositive patients. A decrease in the GSH activity in Toxoplasma seropositive patients indicates a decline in the response to oxidative stresses. The increase of MDA, on the other hand, refers to the increase of lipid peroxidation. The results of our study strongly suggest that one of the main reasons for high MDA levels in Toxoplasma seropositive patients could be a decreased activity of the defense system protecting tissues from free radical damage. It was concluded that an increase in the NO level can be associated with the stimulation of the cell mediated immune system.

REFERENCES

1. Kang KM, Lee GS, Lee JH, Choi IW, Shin DW, Lee YH. Effects of INOS inhibitor on IFN-γ production and apoptosis of splenocytes in genetically different strains of mice infected with Toxoplasma gondii. Korean J Parasitol. 2004. 42:175-183. PMID: 15591835.
crossref pmid pmc
2. Deorari AK, Broor S, Maitreyi RS, Agarwal D, Kumar H, Paul VK, Singh M. Incidence, clinical spectrum and outcome of intrauterine infections in neonates. J Trop Pediatr. 2000. 46:155-159. PMID: 10893916.
crossref pmid
3. Yazar S, Kilic E, Saraymen R, Sahin I. Serum malondialdehyde leves in Toxoplasma seropositive patients. Ann Saudi Med. 2003. 23:413-415. PMID: 16868383.

4. Nishikawa Y, Kawasa O, Vielemeyer O, Suzuki H, Joiner KA, Xuar X, Nagasawa H. Toxoplasma gondii infection induces apoptosis in noninfected macrophages: role of nitric oxide and other soluble factors. Parasite Immunol. 2007. 29:375-385. PMID: 17576367.
crossref pmid
5. Koltas IS, Yucebilgic G, Bilgin R, Parsak CK, Sakman G. Serum malondialdehyde level in patients with cystic echinococcosis. Saudi Med J. 2006. 27:1703-1705. PMID: 17106545.
pmid
6. Uchiyama M, Mihara M. Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978. 34:271-278. PMID: 655387.
crossref
7. Gensert JM, Ratan RR. The metabolic coupling of arginine metabolism to nitric oxide generation by astrocytes. Antioxid Redox Signal. 2006. 8:5-6.

8. Aladag A, Turkoz Y, Ozerol IB. Nitric oxide and its neurophysiopathological effects. Turk J Med Sci. 2000. 20:107-111.

9. Ding M, Kwok LY, Schluter D, Clayton C, Soldati D. The antioxidant systems in Toxoplasma gondii and the role of cytosolic catalase in defence against oxidative injury. Mol Microbiol. 2004. 51:47-61. PMID: 14651610.
pmid
10. Fairbanks V, Klee GG. In Tietz NW ed, Biochemical aspects of hematology. Textbook of Clinical Chemistry. 1986. Philadelphia, USA: W.B. Saunders Co; 1532-1534.

11. Rozenfeld C, Martinez R, Figueiredo RT, Bozza MT, Lima FR, Pires AL, Silva PM, Bonomo A, Lannes-Vieira J, De Souza W, Moura-Neto V. Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration. Infect Immun. 2003. 71:2047-2057. PMID: 12654825.
crossref pmid pmc
12. Daubener W, Posdziech V, Hadding U, Mackenzie CR. Inducuble anti-parasitic effector mechanisms in human uropethelial cells: tryptophan degradation vs. NO production. Med Microbiol Immunol. 1999. 187:143-147. PMID: 10206145.
crossref pmid
13. Yazar S, Kilic E, Saraymen R, Ozbilge H. Serum malondialdehyde levels in patients infected with plasmodium. West Indian Med. 2004. 53:147-149.
pmid
14. Atambay M, Karabulut AB, Aycan OM, Kılıc E, Yazar S, Saraymen R, Karaman U, Daldal N. Dust-mites: effect on lipid peroxidation. Natl Med J India. 2006. 19:75-77. PMID: 16756194.

15. Akkus I. Effects of free radicals and pathophysiological. 1995. Konya, Turkey: Mimoza Publisher: 32; 1-76 ISBN 975-543-038-5.

16. Mercan U. The importance of free radicals in toxicology. YYU J Vet Faculty. 2004. 15:91-96.

Table 1.
Descriptive statistics of glutathione, malondialdehyde, and nitric oxide between seropositive patients and healthy controls
Variables Group n Mean ± SD P value
Glutathione Patients 37 3.96 ± 0.10 0.001
Controls 40 10.37 ± 0.13
Malondialdehyde Patients 37 41.32 ± 2.05 0.001
Controls 40 9.18 ± 1.21
Nitric oxide Patients 37 47.47 ± 1.00 0.001
Controls 40 39.18 ± 1.29
1